Ahead of Market: 10 things that will decide stock market action on Monday
Indian markets closed lower for the second straight week, dragged by weak earnings, US tariff threats, and global uncertainty. IT stocks underperformed while Glenmark Pharma led in turnover. Analysts expect volatility ahead amid weak momentum. Global markets also declined. Over 130 stocks hit 52-week highs despite a broadly bearish sentiment.
How to mix assets like a mad scientist and get rich quietly
A diversified portfolio blending equity, debt, and gold can deliver higher returns with lower volatility, debunking the myth that more equity equals more risk. Strategic asset allocation and rebalancing, rather than speculation, drive long-term stability and growth—backed by real data, correlation benefits, and performance across market cycles.
HCL Tech Q1 preview: Street expects muted sequential show amid seasonal softness. 5 key things to check
HCL Technologies is set to announce Q1FY26 results with analysts projecting flattish sequential growth due to seasonal softness. While revenue may rise 7–8% YoY, margin pressures persist. PAT forecasts diverge across brokerages. Deal wins and guidance retention are expected to support sentiment amid global macro uncertainty.
Market Trading Guide: Asahi India, Cummins India are among 4 stocks to buy on Monday. Up to 20% upside seen in near term
India’s headline indices ended in the red for the third session in a row, as selling pressure in IT, auto and financial stocks weighed on the markets. Nifty has fallen below the 21 EMA on the daily timeframe. Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP Securities said that Nifty continues […]
Know Your Fund Manager | Gurvinder Singh Wasan, CFA, Senior Fund Manager, Baroda BNP Paribas Mutual Fund
With over two decades in fixed income, this Mumbai-born CA and CFA charterholder now leads multiple debt and hybrid funds at Baroda BNP Paribas Mutual Fund. His strategy blends macro insights with tactical moves. The real drive? Earning investors’ trust and delivering alpha while ensuring safety and liquidity.
IPO Calendar: 3 new issues eye Rs 3,600 crore as primary market momentum continues
Three IPOs—Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—aim to raise over Rs 3,600 crore in the week starting July 14. With strong retail interest and sectoral momentum, investor focus remains high. Upcoming listings and grey market trends will guide sentiment amid keen interest in pharma, textiles, and liquor distribution.
Breakout Stocks: How to trade Glenmark Pharma, Jaiprakash Power Ventures & EID Parry that hit fresh 52-week high?
The Indian market closed in the red for the third consecutive day in a row on Friday. The BSE Sensex fell nearly 700 points, while the Nifty50 closed below 25,200 levels.
Time to book profits? Anand James recommends sell on rise strategy for IT stocks
Nifty shows bearish signals with a breakdown below key averages and weakness in IT, despite signs of a short-term rebound. FMCG momentum fades after a failed breakout, while BSE nears support. Stocks like Bharti Hexacom and Aster DM show technical buying potential amid a volatile market outlook.
Mutual fund NFOs: 3 new funds will open for subscription this week
Three mutual fund NFOs—two ETFs and one flexi cap—are opening this week. Investors should evaluate based on risk appetite, goals, and time horizon before subscribing to these new offerings.
Why business cycle funds are all-season investment schemes for volatile markets
Business Cycle Funds adapt to shifting economic conditions by rotating sector exposures like a cricket captain adjusts players based on the pitch. These funds use research-driven strategies to spot inflection points, pick strong companies, and manage risks. Ideal for patient investors seeking tax-efficient, professionally managed exposure to evolving macro trends.